The insider-buying table shows the exact same five names with essentially unchanged dollar figures for a second straight cycle — TSLA (+$219.9M), CRSP (+$28.1M), ASAN (+$8.7M), INTC (+$2.4M), and TSM (+$1.6M, up marginally from +$1.5M) — with no fresh Form-4 filing activity behind any of them. For a third straight cycle, no name in this 59-stock universe closes below RSI 30 on the summary basis — RBLX remains the closest at RSI 39.9 (was 38.7), the insider-flow report's own RSI calculation again reading lower (31↑) on a known basis discrepancy this scan continues to defer to the summary on. BE's three-cycle reversal streak cooled sharply this cycle — its cushion above the 200-day narrowed to +8.0% from +24.6%, RSI fell to 42.6 from 51.1, and the 30-day print flipped back negative to -7.68% from -3.9% — though its one-year return of +349.36% still marks this as a deep pullback inside a massive secular uptrend, not a broken trend. MRNA posted an extraordinary, unexplained move — 7-day +129.02%, 30-day +149.92%, one-year +453.51%, and +197.8% above its 200-day — this desk has no corpus source (news, capture, or event receipt) identifying a driver for any part of this move this session. ARM's 30-day print reversed back negative (-14.14%, was +0.88%), undoing last cycle's "flipped positive for the first time" read, though ARM's one-year return (+82.56%) and 200-day cushion (+23.4%) both stay solidly positive.

Data as-of the 2026-08-21 close. Source: the pre-captured insider Form-4 report (the desk's own tooling, run this session) cross-referenced against summaries/insider-universe.json for every price/RSI/structure/long-horizon field — every price checked matched the summary exactly, and this scan uses only the report's dollar-flow columns, never its own price/RSI/change figures, per standing desk doctrine on this tool's cached-column discrepancy. As flagged in prior cycles, the report's own RSI basis differs from the summary's precomputed RSI on RBLX — the report reads 31↑ versus the summary's 39.9; this scan uses the summary RSI throughout for the "oversold" framing. Prior scan: 2026-08-14-insider-scan.

The insider-buying table is completely unchanged from last cycle, both in composition and in dollar terms. TSLA ($362.86, RSI 58.0, was 48.7; 30D improved to -2.98% from -13.23%) continues with buying frozen at +$219.9M, no fresh filing activity for a fifth-plus straight cycle. CRSP ($59.50, RSI 66.6, was 57.6; 30D +25.95%, was +4.2%) extended its price gains sharply while its buying figure held flat at +$28.1M — a second straight cycle with no confirming second filing. ASAN ($9.58, RSI 61.7, was 59.3), INTC ($90.07, RSI 39.6, was 51.2), and TSM ($418.95, RSI 50.4, was 54.4) all show the same pattern — buying figures essentially unchanged (+$8.7M, +$2.4M, +$1.6M respectively) against real price movement underneath. This reads as a genuinely quiet Form-4 cycle rather than a data-fetch gap.

No name in this 59-stock universe closes below RSI 30 for a third straight cycle. RBLX ($38.37, RSI 39.9, was 38.7) held essentially flat, its 30-day print deepening further to -22.7%. Insider selling on RBLX sits at -$695.4M, essentially flat versus -$698.7M last cycle. RBLX's longer-horizon numbers confirm this is a name whose structure, not just its near-term price, is under real pressure: -39.2% below its 200-day, -66.59% on the year, alpha1y of -88.41%, collapse regime with a death cross. On the golden-signal (RSI<30 plus buying) and selling-into-dip (RSI<30 plus selling) criteria, both again return zero names.

BE's multi-cycle reversal cooled sharply this cycle, though the longer-horizon read still favors the trend over the pullback. Price fell to $201.45 (RSI 42.6, was 51.1), and the cushion above the 200-day narrowed to +8.0% from +24.6% (three straight prior cycles of widening) — the 30-day print flipped back to -7.68% from -3.9%. This ends the confirming streak flagged over the last three cycles. But BE's one-year return is +349.36% with alpha1y at +327.55%, and its regime label (pullback, thesis: intact) hasn't downgraded — this reads as a real cooldown inside a still-enormous secular move, not evidence the reversal itself has broken. Insider selling stayed roughly flat at -$460.8M (was -$451.4M) — still price-driven, not corroborated by fresh insider buying.

MRNA posted an extraordinary, unexplained move this cycle. ($145.13, RSI 71.6; 7D +129.02%, 30D +149.92%, one-year +453.51%, +197.8% above its 200-day, alpha1y +431.69%) — every field is verified directly against the summary, and this desk has no news, capture, or event receipt from this session identifying what drove any part of this move. A move of this size with no known catalyst is flagged explicitly as cause unknown, not glossed over with an inferred narrative.

ARM's 30-day print reversed back negative, undoing last cycle's "flipped positive" read — but the longer-horizon numbers stay solidly positive. ($243.32, RSI 39.2, was 50.9; 30D -14.14%, was +0.88%; 7D -12.89%) pulled back sharply on the short window. Its one-year return is +82.56% and it remains +23.4% above its 200-day (thesis: intact-but-priced) — this reads as a deep pullback inside an intact trend, consistent with the same-cycle pattern flagged across the semis-adjacent names in the companion tech-insider-buys scan.

The semis-adjacent complex broadly cooled on the short window while staying positive on the year. AMD (RSI 45.8, 30D -14.32%, change1y +189.08%, vs-SMA200 +43.5%), INTC (RSI 39.6, 30D -12.23%, change1y +283.28%, vs-SMA200 +26.0%), MRVL (RSI 55.8, change1y +232.87%, vs-SMA200 +63.4%), and ASML (RSI 50.5, change1y +139.84%, vs-SMA200 +21.9%) all cooled meaningfully on 7D/30D while remaining deeply positive on the year and well above their 200-days. ISRG (RSI 47.6, was 56.0; regime now collapse, vs-SMA200 -19.9%, change1y -19.38%) is the exception in this group — its thesisState is still tagged intact, but the chart itself has moved below its 200-day with a negative one-year return, worth flagging as a name where the price structure and the thesis flag now disagree.

Heavy insider selling stayed essentially frozen across the top-20 dollar-value names. AMZN (-$9.6B), NVDA (-$3.3B), LLY (-$3.1B), PLTR (-$2.3B), and AVGO (-$1.6B) all held their prior-cycle figures exactly. AMD's selling deepened to -$410.2M from -$389.2M. DDOG's captured figure moved to -$668.9M from -$737.1M. SNOW ticked up to -$1.3B from -$1.2B.

This is a price-and-structure screen cross-referenced with insider Form-4 net dollars — not a recommendation engine. The buying table's second straight cycle of zero fresh filings is a genuinely quiet read on insider conviction in this universe, not a data gap — every name's dollar figure either matched last cycle's exactly or moved by a negligible amount. A universe-wide absence of any RSI<30 name across three straight cycles says the tape has stabilized broadly in this universe, not that every name here is a buy. Structure labels — intact (golden cross, uptrend/basing), damaged (death cross, downtrend/collapse), extended (large positive vs-SMA200 in an uptrend) — describe the chart only. Per the desk's long-horizon discipline, a cooling short-window read (BE, ARM) is checked against change1y and vs-SMA200 before it gets called a broken trend — both stayed intact this cycle for both names. MRNA's move is reported at full size because it is verified against the summary, and flagged as cause unknown because it is: this desk has no receipt for it.

(No other name in this universe shows net insider buying above $100K this cycle.)

(51+ names show net insider selling this cycle per the pull; the 20 above are the largest captured. Other names in the 08-14 top-20 not restated here superseded by RBLX's larger figure this cycle.)

None this cycle. RBLX, the closest candidate, sits at RSI 39.9 on the summary basis — above the strict RSI-30 threshold for a third straight cycle — with -$695.4M in insider selling (essentially flat vs -$698.7M).

Buying table frozen for a second cycle — no fresh Form-4 activity across TSLA, CRSP, ASAN, INTC, or TSM; treat the dollar figures as continuing prior conviction, not fresh signal.

Universe-wide clean read extends to a third cycle — no name closes below RSI 30 anywhere in this 59-stock universe; both the golden-signal and selling-into-dip criteria return zero.

Reversal cooling, trend still intact — BE's cushion above the 200-day narrowed sharply, but its one-year return (+349.36%) keeps this read as a pullback rather than a break.

Extraordinary, unexplained move — MRNA's 30-day and one-year prints are the largest in this universe by a wide margin; no corpus source for the driver.

Semis-adjacent complex cools on the short window, stays positive on the year — AMD, INTC, MRVL, ASML, ARM all pulled back on 7D/30D while remaining well above their 200-days with large positive one-year returns.

Heavy selling, intact structure — AMZN, NVDA, LLY, PANW, ABNB, SNOW, NET, DOCN, DDOG, TWLO, AAPL, AMD all show large insider-selling dollars inside intact (golden-cross) technical structure — reads as scale-driven, not a bearish tell on its own.

Heavy selling, damaged structure — verification-worthy — PLTR, NFLX, COIN, SOFI, ESTC, RBLX.

• Tape data (price/RSI/SMA/returns/change1y/alpha1y/vsSma200): full-scan pre-computed summaries as of the 2026-08-21 close — insider-universe.
• Insider Form-4 net dollar flows: pre-captured insider-scan:full report (run this session) — no discrepancies found on price for the names it did capture; RSI-basis gap on RBLX noted above.